Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:TG 18:1_20:4_24:5)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteAnalysis Type
ST003988 AN006569 Lipid and cell cycling perturbations driven by the HDAC inhibitor romidepsin render liver cancer vulnerable to RTK targeting and immunologically active Cultured cells Human Cancer CNRS LC-MS
ST003130 AN005133 Pulmonary maternal immune activation does not extend through the placenta but leads to fetal metabolic adaptation - Maternal blood Blood Mouse University of Copenhagen LC-MS
  logo